Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1351-1360 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|January 24, 2012
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathwayVesselina G Cooke, Valerie S LeBleu, Doruk Keskin, et al.
Cancer Cell|January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugsAstrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Cancer Cell|January 24, 2012
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinomaJianhua Ling, Ya'an Kang, Ruiying Zhao, et al.
Cancer Cell|December 17, 2011
"Ring-fencing" BRCA1 tumor suppressor activityKetan J Patel, Gerry P Crossan, Michael R G Hodskinson
Cancer Cell|December 17, 2011
Many tumors in one: a daunting therapeutic prospectChibawanye I Ene, Howard A Fine
Cancer Cell|December 17, 2011
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancerKathleen Anders, Christian Buschow, Andreas Herrmann, et al.
Cancer Cell|April 21, 2012
Breaking the LSD1/KDM1A addiction: therapeutic targeting of the epigenetic modifier in AMLAlyson A Lokken, Nancy J Zeleznik-Le
Cancer Cell|April 21, 2012
Hijacking T cell differentiation: new insights in TLX function in T-ALLBryan King, Panagiotis Ntziachristos, Iannis Aifantis
Cancer Cell|April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALLPrem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
Cancer Cell|April 21, 2012
Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistanceElizabeth S Nakasone, Hanne A Askautrud, Tim Kees, et al.
Pageof 383

Showing results (1351-1360 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|January 24, 2012
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathwayVesselina G Cooke, Valerie S LeBleu, Doruk Keskin, et al.
Cancer Cell|January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugsAstrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Cancer Cell|January 24, 2012
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinomaJianhua Ling, Ya'an Kang, Ruiying Zhao, et al.
Cancer Cell|December 17, 2011
"Ring-fencing" BRCA1 tumor suppressor activityKetan J Patel, Gerry P Crossan, Michael R G Hodskinson
Cancer Cell|December 17, 2011
Many tumors in one: a daunting therapeutic prospectChibawanye I Ene, Howard A Fine
Cancer Cell|December 17, 2011
Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancerKathleen Anders, Christian Buschow, Andreas Herrmann, et al.
Cancer Cell|April 21, 2012
Breaking the LSD1/KDM1A addiction: therapeutic targeting of the epigenetic modifier in AMLAlyson A Lokken, Nancy J Zeleznik-Le
Cancer Cell|April 21, 2012
Hijacking T cell differentiation: new insights in TLX function in T-ALLBryan King, Panagiotis Ntziachristos, Iannis Aifantis
Cancer Cell|April 21, 2012
Targeting nonclassical oncogenes for therapy in T-ALLPrem S Subramaniam, Dosh W Whye, Evgeni Efimenko, et al.
Cancer Cell|April 21, 2012
Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistanceElizabeth S Nakasone, Hanne A Askautrud, Tim Kees, et al.
Pageof 383